CHRISTOPHER OTERO: Open Payments
NPI 1346928090 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,718 in 35 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,671 · 2025 $4,718
Food & beverage: $3,098Consulting: $1,620
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $2,393 |
| AstraZeneca Pharmaceuticals LP | 7 | $692 |
| EMD Serono, Inc. | 1 | $146 |
| Genentech USA, Inc. | 1 | $143 |
| Dendreon Pharmaceuticals LLC | 1 | $135 |
| Novocure Inc. | 1 | $131 |
| Caris MPI, Inc. | 2 | $128 |
| SOBI, INC | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
Products named: RYBREVANT, PROVENGE, Optune Lua (NovoTTF-200T), MI CANCER SEEK, Vonjo, FRUZAQLA, BRUKINSA, ZEPZELCA.
Industry payments across FL — which companies pay providers there.
